Biomarkers for monitoring remodeling in a patient after a myocardial infarction

Posted in the Cardiology Forum

Sciclips

Madison, WI

#1 Sep 2, 2011
A recent US patent application describes the use of biomarkers for monitoring success of remodeling in a patient after a myocardial infarction, wherein the remodeling is supported by treatment or a combination of treatments. A difference of 40% in inflammatory marker, osteopontin, indicates that administration of the drug can be lowered. A difference of 40% in inflammatory markers, osteopontin and GDF-15, indicates that administration of the drug can be lowered. A decrease to a difference of 33 pg/ml CRP indicates that administration of a drug can be lowered. News link: http://www.sciclips.com/sciclips/biomarker-ne...

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Cardiology Discussions

Title Updated Last By Comments
News Cardiologists, Veterinarian Work Together to Fi... May 18 Go Blue Forever 4
Possible PVCs May 10 Ashley12 1
heart rhythm off. skips a beat and speeds up fo... (Aug '08) Apr 29 charlysmommy1 105
stress test EKG Apr '15 Mercedes 1
Interpreting results of nuclear stress test (Jan '11) Mar '15 Lynn 9
News One in 4 patients who visited emergency departm... Feb '15 LHIN 1
I think there is a serious error in the usual E... Feb '15 Leonid Asipov 1
More from around the web